Related Experiment Videos
Effects of vasodilators on the coronary circulation in congestive heart failure
1Department of Medicine, University Hospital, Kantonsspital Basel, Switzerland.
Insights
Cardiac hypertrophy increases myocardial oxygen demand. Vasodilators
Area of Science:
- Cardiovascular Physiology
- Pharmacology
Background:
- Myocardial hypertrophy, a response to pressure or volume overload, increases wall stress and oxygen demand.
- Despite compensatory hypertrophy, reduced subendocardial flow and increased coronary resistance can impair oxygen supply.
- The risk of vasodilator-induced steal phenomenon, shunting blood from ischemic areas, is a concern in hypertrophic hearts.
Purpose of the Study:
- To review the effects of various vasodilators on coronary circulation and myocardial oxygen supply-demand balance in cardiac hypertrophy.
- To assess the clinical utility of vasodilators in managing congestive heart failure with special attention to coronary hemodynamics.
Main Methods:
- Literature review of studies investigating vasodilator effects in cardiac hypertrophy and congestive heart failure.
- Analysis of data on coronary blood flow, myocardial oxygen consumption, and vascular resistance in response to different drug classes.
Main Results:
- Angiotensin-converting enzyme inhibitors showed parallel reduction in oxygen consumption and coronary blood flow, suggesting preserved autoregulation, with some evidence of vasodilation.
- Calcium antagonists reduce coronary resistance and improve the supply-demand ratio, but the clinical benefit of newer agents needs further study.
- Hydralazine and alpha-adrenergic blockers improved the oxygen demand-supply ratio, but potential metabolic deterioration was noted with hydralazine in coronary heart disease patients.
Conclusions:
- Understanding coronary circulation in heart failure is advancing, but further research with refined methodologies is needed.
- The precise role and clinical efficacy of newer vasodilators in hypertrophic cardiomyopathy require continued investigation.
- Optimizing myocardial oxygen supply-demand balance remains a critical therapeutic goal in heart failure management.
Abstract:
Pressure or volume overload of the myocardium increases the wall stress, particularly of the subendocardium, and leads to hypertrophy. Even though cardiac hypertrophy is viewed as a beneficial compensatory process that normalizes wall stress, the increased muscle mass carries with it the need of increased blood supply. Overall flow per unit mass is similar at rest in hypertrophic and normal hearts but a reduction of flow to the subendocardium and an increase in minimal coronary vascular resistance have been described. Thus, the potential exists for a vasodilator-induced steal mechanism shunting blood away from potentially ischemic areas. Angiotensin-converting enzyme inhibitors reduced myocardial oxygen consumption and coronary blood flow in parallel manner in some studies, indicating preserved coronary autoregulation, but there is also some evidence of a coronary vasodilator effect. Calcium antagonists reduce coronary vascular resistance and improve the myocardial demand-supply ratio, but the clinical usefulness of the newer compounds with supposedly little or no negative inotropic effects remains to be established. Hydralazine improved the myocardial oxygen demand-supply ratio in patients with dilated cardiomyopathy, but metabolic function may deteriorate more often after hydralazine than after angiotensin-converting enzyme inhibitors in patients with coronary heart disease. Similar observations have been made using alpha-adrenergic blockers. Although progress has been made in the understanding of the coronary circulation and the influence of vasodilators in congestive heart failure, many questions await clarification using refined or new methodology.